Tuberculosis News and Research

Latest Tuberculosis News and Research

Global Fund Board announces integration of AMFm into core grant system

The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria on Thursday announced it will "integrate" the Affordable Medicines Facility-malaria (AMFm), implemented in 2010 as a pilot program to provide low-cost artemisinin-based combination therapies (ACTs) in poor and rural areas, "into its existing core system of providing grants to countries to purchase drugs, bed nets and other malaria-control measures," Nature News Blog reports.

17 Nov 2012

Global Fund Board votes to begin immediate transition to new funding model

"In a bid to ensure the global fight against three of the world's most devastating diseases remains efficient, the Board of the ... Global Fund to Fight AIDS, Tuberculosis and Malaria voted Thursday to begin an immediate transition" to a new grant-funding approach, the U.N. News Centre reports.

17 Nov 2012

USAID helping to move health forward in Burma

Ariel Pablos-Mendez, USAID assistant administrator for global health, writes in the agency's IMPACTblog about his recent trip to Burma and the challenges the country faces as it transitions to an open society.

16 Nov 2012

Global Fund board terminates employment of Inspector General

"The Global Fund to Fight AIDS, Tuberculosis and Malaria said in a statement Thursday that its board had terminated the employment of Inspector General John Parsons 'after a careful review of his performance, which was found to be unsatisfactory,'" the Associated Press reports.

16 Nov 2012

FCTC funding cuts could leave world's poorest countries vulnerable to smoking-related diseases

Proposed funding cuts within the international body responsible for tobacco control will leave the world's poorest countries more vulnerable to smoking-related diseases, a study suggests.

16 Nov 2012

Global Fund uncovers 'financial wrongdoing' in some grants to Cambodia

The Global Fund to Fight AIDS, Tuberculosis and Malaria on Wednesday said an investigation by the group's Inspector General into grants in Cambodia "uncovered credible and substantive evidence of serious financial wrongdoing, on procurement and other issues," Agence France-Presse reports.

16 Nov 2012

New 'people-centered investment approach' could lead to end of global AIDS pandemic

Writing in Huffington Post's "The Big Push" blog, Lucy Chesire, executive director and secretary to the board of the TB ACTION Group, notes "countries from north and south, U.N. organizations, private sector companies and non-governmental organizations (NGOs) are meeting in Geneva [this week] at the Board meeting of the Global Fund to Fight AIDS, Tuberculosis and Malaria to discuss how best to invest available resources against the three killer diseases."

16 Nov 2012

Report provides recommendations for action on TB among children

In a guest post on the Global Health Technology Coalition's "Breakthroughs" blog, Mandy Slutsker, senior project associate with the ACTION Partnership, describes a new report that calls for increased efforts to fight tuberculosis (TB) among children worldwide (Lufkin, 11/13).

15 Nov 2012

Viewpoints: Voters want Medicare protected in 'grand bargain;' Increases in taxes can't cover the 'fiscal cliff'; Kids' health needs more attention

As the ranking member on the House Financial Services Subcommittee on Domestic Monetary Policy and Technology, let me simply state the hard truth. To avoid the fiscal cliff and to get our budget deficit and the national debt under control, we need to do three things simultaneously: cut spending, increase revenue and have the courage to put everything on the table in a responsible, bipartisan manner.

15 Nov 2012

Greece faces return of malaria, other public health issues since 2009 economic crash

The Wall Street Journal examines how "Greece has seen decades of advances in public health rolled back, as a flood of illegal immigrants, a dysfunctional government and budget cuts ravage a once proud health-care system."

15 Nov 2012

Tuberculosis pathogen has an ingenious defence mechanism against oxygen

Flemish biologists lead by Joris Messens (VIB / Vrije Universiteit Brussel) have discovered that Mycobacterium tuberculosis - the bacterium that causes tuberculosis - has an ingenious defence mechanism against oxygen. This knowledge is important in the search for a treatment for tuberculosis. 9.4 million people are infected with tuberculosis annually and 1.7 million people die as a result.

15 Nov 2012

Global health community should save AMFm because it saves lives

The Affordable Medicines Facility-malaria began as a pilot program in 2010 to "provide a 'co-payment' to the manufacturers of [artemisinin-based combination therapies (ACTs)], thereby allowing commercial wholesalers and private or government health services to purchase the drugs at a fraction of the already low negotiated price," Kenneth Arrow, a Nobel laureate in economic sciences in 1972 and an emeritus professor of economics at Stanford University, writes in a New York Times opinion piece.

15 Nov 2012

BMJ examines history, future of Global Fund to Fight AIDS, Tuberculosis and Malaria

The BMJ examines the history of fraud allegations against the Global Fund to Fight AIDS, Tuberculosis and Malaria and the organization's ongoing reform efforts.

14 Nov 2012

U.N., partners call for greater efforts to fight number one killer of children on World Pneumonia Day

On World Pneumonia Day (WPD), recognized on November 12, "the United Nations and its partners ... called for greater efforts to eradicate pneumonia, the number one killer of children under the age of five," the U.N. News Centre reports.

14 Nov 2012

International community must step up fight against TB in Southern African region

"With $2.5 trillion in mineral reserves, South Africa has the largest mining sector in the world," but "[t]he work can be devastatingly toxic for the body," with "inhumane and untenable" working conditions, Archbishop Desmond Tutu, archbishop emeritus of Cape Town, South Africa, writes in a Wall Street Journal opinion piece.

9 Nov 2012

Elevated ST2 biomarker levels strongly indicate heart failure and mortality in HIV patients

Critical Diagnostics, makers of the Presage ST2 Assay, announced today that during a presentation at the American Heart Association Scientific Sessions in Los Angeles, the results of a study demonstrated that elevated levels of the biomarker ST2 in HIV patients was strongly indicative of the development of heart failure and mortality.

9 Nov 2012

Key areas of disease neglected by UK funding for infectious diseases

UK funding for infectious diseases research is neglecting some of the diseases that result in the highest rates of death and disability, according to an Article published Online First in The Lancet Infectious Diseases.

8 Nov 2012

Teva announces additional data from QNASL Phase III program on seasonal allergic rhinitis

Teva Pharmaceutical Industries Ltd. announced today that additional data from the Phase III clinical program for QNASL- (beclomethasone dipropionate) Nasal Aerosol will be presented at the 2012 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Anaheim, CA on November 8-13, 2012.

7 Nov 2012

Aidspan publishes new issue of 'Global Fund Observer'

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Monday published Issue 201 of its "Global Fund Observer."

7 Nov 2012

IRIN examines intellectual property protection in South Africa

IRIN examines how patents and intellectual property protection in South Africa affects patients' access to medicines. "A form of intellectual property protection, patents are typically awarded to companies that can prove their product is new," IRIN writes, adding, "Not so in South Africa, say activists and researchers, who claim the country's patent system allows pharmaceutical companies to apply for new patents on existing drugs based on immaterial changes -- like adding table salt to a formulation or changing a pill's color."

7 Nov 2012

Tuberculosis News and Research

Latest Tuberculosis News and Research

Global Fund Board announces integration of AMFm into core grant system

Global Fund Board votes to begin immediate transition to new funding model

USAID helping to move health forward in Burma

Global Fund board terminates employment of Inspector General

FCTC funding cuts could leave world's poorest countries vulnerable to smoking-related diseases

Global Fund uncovers 'financial wrongdoing' in some grants to Cambodia

New 'people-centered investment approach' could lead to end of global AIDS pandemic

Report provides recommendations for action on TB among children

Viewpoints: Voters want Medicare protected in 'grand bargain;' Increases in taxes can't cover the 'fiscal cliff'; Kids' health needs more attention

Greece faces return of malaria, other public health issues since 2009 economic crash

Tuberculosis pathogen has an ingenious defence mechanism against oxygen

Global health community should save AMFm because it saves lives

BMJ examines history, future of Global Fund to Fight AIDS, Tuberculosis and Malaria

U.N., partners call for greater efforts to fight number one killer of children on World Pneumonia Day

International community must step up fight against TB in Southern African region

Elevated ST2 biomarker levels strongly indicate heart failure and mortality in HIV patients

Key areas of disease neglected by UK funding for infectious diseases

Teva announces additional data from QNASL Phase III program on seasonal allergic rhinitis

Aidspan publishes new issue of 'Global Fund Observer'

IRIN examines intellectual property protection in South Africa

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in